Mounjaro - NDC Database

12 records found
Page:1
0002-1152 Jul 28, 2023
Mounjaro 2.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-1243 Jul 28, 2023
Mounjaro 5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-1457 May 13, 2022
Mounjaro 15 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-1460 May 13, 2022
Mounjaro 12.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-1471 May 13, 2022
Mounjaro 10 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-1484 May 13, 2022
Mounjaro 7.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-1495 May 13, 2022
Mounjaro 5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-1506 May 13, 2022
Mounjaro 2.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-2214 Jul 28, 2023
Mounjaro 7.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-2340 Jul 28, 2023
Mounjaro 10 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-2423 Jul 28, 2023
Mounjaro 12.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-3002 Jul 28, 2023
Mounjaro 15 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.